Estimaciones de analistas de Wall Street para InflaRx N.V. (IFRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.07 | ||
| 2026-08-06 | $-0.11 | $-0.07 | -65.1% |
| 2026-05-07 | $-0.09 | $-0.17 | +47.1% |
| 2026-03-19 | $-0.17 | $-0.18 | +5.6% |
| 2025-11-10 | $-0.16 | $-0.16 | +0.0% |
| 2025-08-07 | $-0.24 | $-0.24 | +0.0% |
| 2025-05-07 | $-0.14 | $-0.18 | +22.2% |
| 2025-03-20 | $-0.09 | $-0.27 | +66.7% |
Ratios de valoración
| Precio / Valor contable | 1.38 |
| EV / EBITDA | -3.32 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $63089 | $165789 | $29331 |
| Coste de Ventas | $35658 | $66691 | $179570 | 0 | 0 | 0 | 0 | $532262 | $3.3M | $7.3M |
| Beneficio Bruto | -$35658 | -$68420 | -$179570 | 0 | 0 | 0 | 0 | -$469173 | -$3.2M | -$7.2M |
| I+D | $5.3M | $14.4M | $25.0M | $44.6M | $25.7M | $35.7M | $37.5M | $41.0M | $35.4M | $25.7M |
| Generales y Administrativos | $1.8M | $5.1M | $12.8M | $12.5M | $7.9M | $11.4M | $14.3M | $16.1M | $19.3M | $17.6M |
| Gastos Operativos | $6.9M | $18.8M | $37.5M | $56.8M | $33.9M | $47.6M | $32.2M | $44.1M | $49.8M | $41.0M |
| Beneficio Operativo | -$6.9M | -$19.4M | -$37.5M | -$56.8M | -$33.9M | -$47.6M | -$32.2M | -$44.6M | -$52.9M | -$48.3M |
| EBITDA | -$7.1M | -$19.6M | -$37.3M | -$56.5M | -$33.6M | -$44.9M | -$28.8M | -$42.1M | -$45.6M | -$45.2M |
| Gastos por Intereses | $1.8M | $2.2M | 0 | $22200 | $26000 | $24769 | $45250 | $35628 | $20655 | $37690 |
| Beneficio Antes de Impuestos | -$8.9M | -$24.2M | -$29.8M | -$53.3M | -$34.0M | -$45.6M | -$29.5M | -$42.7M | -$46.1M | -$45.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5217 | $12282 |
| Beneficio Neto | -$8.9M | -$24.2M | -$29.8M | -$53.3M | -$34.0M | -$45.6M | -$29.5M | -$42.7M | -$46.1M | -$45.6M |
| BPA | $-0.38 | $-1.03 | $-1.19 | $-1.91 | $-1.26 | $-1.10 | $-0.61 | $-0.78 | $-0.78 | $-0.66 |
| BPA Diluido | $-0.38 | $-1.03 | $-1.19 | $-1.91 | $-1.26 | $-1.10 | $-0.61 | $-0.78 | $-0.78 | $-0.66 |
| Acciones en Circulación (Diluidas) | $23.4M | $23.6M | $25.1M | $26.0M | $27.1M | $41.6M | $44.2M | $54.9M | $58.9M | $67.3M |
Precio
| Precio | $2.04 |
| Capitalización | $300M |
| Bolsa | NASDAQ |
| País | DE |
Empresas relacionadas: ARTV · ATYR · CNTB · CNTX · IMA · KLRS · MGX
Explorar sector: Healthcare · Biotechnology
Más secciones de IFRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones